879 related articles for article (PubMed ID: 28596174)
1. Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications.
Yoshida Y; Yamanaka S
Circ Res; 2017 Jun; 120(12):1958-1968. PubMed ID: 28596174
[TBL] [Abstract][Full Text] [Related]
2. Generation of human cardiomyocytes for cardiac regenerative therapies: differentiation and direct reprogramming.
Hodonsky C; Wu K; Mundada L; Si MS
Curr Pharm Des; 2014; 20(12):2012-22. PubMed ID: 23844731
[TBL] [Abstract][Full Text] [Related]
3. Exosomes Generated From iPSC-Derivatives: New Direction for Stem Cell Therapy in Human Heart Diseases.
Jung JH; Fu X; Yang PC
Circ Res; 2017 Jan; 120(2):407-417. PubMed ID: 28104773
[TBL] [Abstract][Full Text] [Related]
4. Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications.
Sadahiro T; Yamanaka S; Ieda M
Circ Res; 2015 Apr; 116(8):1378-91. PubMed ID: 25858064
[TBL] [Abstract][Full Text] [Related]
5. Safe and Effective Cardiac Regenerative Therapy With Human-Induced Pluripotent Stem Cells: How Should We Prepare Pure Cardiac Myocytes?
Tohyama S; Fukuda K
Circ Res; 2017 May; 120(10):1558-1560. PubMed ID: 28495993
[No Abstract] [Full Text] [Related]
6. Future prospects for regenerated heart using induced pluripotent stem cells.
Fujita J; Fukuda K
J Pharmacol Sci; 2014; 125(1):1-5. PubMed ID: 24739283
[TBL] [Abstract][Full Text] [Related]
7. iPS cells: a source of cardiac regeneration.
Yoshida Y; Yamanaka S
J Mol Cell Cardiol; 2011 Feb; 50(2):327-32. PubMed ID: 21040726
[TBL] [Abstract][Full Text] [Related]
8. Human-Induced Pluripotent Stem Cell Technology and Cardiomyocyte Generation: Progress and Clinical Applications.
Di Baldassarre A; Cimetta E; Bollini S; Gaggi G; Ghinassi B
Cells; 2018 May; 7(6):. PubMed ID: 29799480
[TBL] [Abstract][Full Text] [Related]
9. Stem cells as therapy for heart disease: iPSCs, ESCs, CSCs, and skeletal myoblasts.
Rikhtegar R; Pezeshkian M; Dolati S; Safaie N; Afrasiabi Rad A; Mahdipour M; Nouri M; Jodati AR; Yousefi M
Biomed Pharmacother; 2019 Jan; 109():304-313. PubMed ID: 30396088
[TBL] [Abstract][Full Text] [Related]
10. Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell-based regeneration.
Yoshida Y; Yamanaka S
Circulation; 2010 Jul; 122(1):80-7. PubMed ID: 20606130
[No Abstract] [Full Text] [Related]
11. Steps toward safe cell therapy using induced pluripotent stem cells.
Okano H; Nakamura M; Yoshida K; Okada Y; Tsuji O; Nori S; Ikeda E; Yamanaka S; Miura K
Circ Res; 2013 Feb; 112(3):523-33. PubMed ID: 23371901
[TBL] [Abstract][Full Text] [Related]
12. Role of somatic cell sources in the maturation degree of human induced pluripotent stem cell-derived cardiomyocytes.
Pianezzi E; Altomare C; Bolis S; Balbi C; Torre T; Rinaldi A; Camici GG; Barile L; Vassalli G
Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118538. PubMed ID: 31472168
[TBL] [Abstract][Full Text] [Related]
13. Maturation status of sarcomere structure and function in human iPSC-derived cardiac myocytes.
Bedada FB; Wheelwright M; Metzger JM
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1829-38. PubMed ID: 26578113
[TBL] [Abstract][Full Text] [Related]
14. Generating patient-specific induced pluripotent stem cells-derived cardiomyocytes for the treatment of cardiac diseases.
Jeziorowska D; Korniat A; Salem JE; Fish K; Hulot JS
Expert Opin Biol Ther; 2015; 15(10):1399-409. PubMed ID: 26134098
[TBL] [Abstract][Full Text] [Related]
15. Induced pluripotent stem cell technology: Toward the future of cardiac arrhythmias.
Gnecchi M; Stefanello M; Mura M
Int J Cardiol; 2017 Jun; 237():49-52. PubMed ID: 28408106
[TBL] [Abstract][Full Text] [Related]
16. Induced Pluripotent Stem Cell (iPSC)-Derived Extracellular Vesicles Are Safer and More Effective for Cardiac Repair Than iPSCs.
Adamiak M; Cheng G; Bobis-Wozowicz S; Zhao L; Kedracka-Krok S; Samanta A; Karnas E; Xuan YT; Skupien-Rabian B; Chen X; Jankowska U; Girgis M; Sekula M; Davani A; Lasota S; Vincent RJ; Sarna M; Newell KL; Wang OL; Dudley N; Madeja Z; Dawn B; Zuba-Surma EK
Circ Res; 2018 Jan; 122(2):296-309. PubMed ID: 29118058
[TBL] [Abstract][Full Text] [Related]
17. Non-viral reprogramming and induced pluripotent stem cells for cardiovascular therapy.
Panda A; Gurusamy N; Rajasingh S; Carter HK; Thomas EL; Rajasingh J
Differentiation; 2020; 112():58-66. PubMed ID: 31954271
[TBL] [Abstract][Full Text] [Related]
18. Induced regeneration--the progress and promise of direct reprogramming for heart repair.
Addis RC; Epstein JA
Nat Med; 2013 Jul; 19(7):829-36. PubMed ID: 23836233
[TBL] [Abstract][Full Text] [Related]
19. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
[TBL] [Abstract][Full Text] [Related]
20. Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease.
Davis RP; Casini S; van den Berg CW; Hoekstra M; Remme CA; Dambrot C; Salvatori D; Oostwaard DW; Wilde AA; Bezzina CR; Verkerk AO; Freund C; Mummery CL
Circulation; 2012 Jun; 125(25):3079-91. PubMed ID: 22647976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
